List of Tables
Table 1. Global Point-of-care Testing (POCT) for Substance Abuse Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Point-of-care Testing (POCT) for Substance Abuse Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Point-of-care Testing (POCT) for Substance Abuse Market Competitive Situation by Manufacturers in 2024
Table 4. Global Point-of-care Testing (POCT) for Substance Abuse Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Point-of-care Testing (POCT) for Substance Abuse Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Point-of-care Testing (POCT) for Substance Abuse Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Point-of-care Testing (POCT) for Substance Abuse, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Point-of-care Testing (POCT) for Substance Abuse, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Point-of-care Testing (POCT) for Substance Abuse, Product Type & Application
Table 12. Global Key Manufacturers of Point-of-care Testing (POCT) for Substance Abuse, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Point-of-care Testing (POCT) for Substance Abuse by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Testing (POCT) for Substance Abuse as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Point-of-care Testing (POCT) for Substance Abuse Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Point-of-care Testing (POCT) for Substance Abuse Sales by Region (2020-2025) & (K Units)
Table 18. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Region (2020-2025)
Table 19. Global Point-of-care Testing (POCT) for Substance Abuse Sales by Region (2026-2031) & (K Units)
Table 20. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Region (2026-2031)
Table 21. Global Point-of-care Testing (POCT) for Substance Abuse Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Region (2020-2025)
Table 23. Global Point-of-care Testing (POCT) for Substance Abuse Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Region (2026-2031)
Table 25. North America Point-of-care Testing (POCT) for Substance Abuse Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Point-of-care Testing (POCT) for Substance Abuse Sales by Country (2020-2025) & (K Units)
Table 27. North America Point-of-care Testing (POCT) for Substance Abuse Sales by Country (2026-2031) & (K Units)
Table 28. North America Point-of-care Testing (POCT) for Substance Abuse Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Point-of-care Testing (POCT) for Substance Abuse Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Point-of-care Testing (POCT) for Substance Abuse Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Point-of-care Testing (POCT) for Substance Abuse Sales by Country (2020-2025) & (K Units)
Table 32. Europe Point-of-care Testing (POCT) for Substance Abuse Sales by Country (2026-2031) & (K Units)
Table 33. Europe Point-of-care Testing (POCT) for Substance Abuse Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Point-of-care Testing (POCT) for Substance Abuse Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Point-of-care Testing (POCT) for Substance Abuse Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Point-of-care Testing (POCT) for Substance Abuse Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Point-of-care Testing (POCT) for Substance Abuse Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Point-of-care Testing (POCT) for Substance Abuse Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Point-of-care Testing (POCT) for Substance Abuse Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Point-of-care Testing (POCT) for Substance Abuse Sales (K Units) by Type (2020-2025)
Table 51. Global Point-of-care Testing (POCT) for Substance Abuse Sales (K Units) by Type (2026-2031)
Table 52. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Type (2020-2025)
Table 53. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Type (2026-2031)
Table 54. Global Point-of-care Testing (POCT) for Substance Abuse Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Point-of-care Testing (POCT) for Substance Abuse Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Type (2020-2025)
Table 57. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Type (2026-2031)
Table 58. Global Point-of-care Testing (POCT) for Substance Abuse Price (US$/Unit) by Type (2020-2025)
Table 59. Global Point-of-care Testing (POCT) for Substance Abuse Price (US$/Unit) by Type (2026-2031)
Table 60. Global Point-of-care Testing (POCT) for Substance Abuse Sales (K Units) by Application (2020-2025)
Table 61. Global Point-of-care Testing (POCT) for Substance Abuse Sales (K Units) by Application (2026-2031)
Table 62. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Application (2020-2025)
Table 63. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Application (2026-2031)
Table 64. Global Point-of-care Testing (POCT) for Substance Abuse Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Point-of-care Testing (POCT) for Substance Abuse Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Application (2020-2025)
Table 67. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Application (2026-2031)
Table 68. Global Point-of-care Testing (POCT) for Substance Abuse Price (US$/Unit) by Application (2020-2025)
Table 69. Global Point-of-care Testing (POCT) for Substance Abuse Price (US$/Unit) by Application (2026-2031)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Roche Point-of-care Testing (POCT) for Substance Abuse Product
Table 74. Roche Recent Developments/Updates
Table 75. Danaher Company Information
Table 76. Danaher Description and Business Overview
Table 77. Danaher Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Danaher Point-of-care Testing (POCT) for Substance Abuse Product
Table 79. Danaher Recent Developments/Updates
Table 80. Abbott Company Information
Table 81. Abbott Description and Business Overview
Table 82. Abbott Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Abbott Point-of-care Testing (POCT) for Substance Abuse Product
Table 84. Abbott Recent Developments/Updates
Table 85. Siemens Company Information
Table 86. Siemens Description and Business Overview
Table 87. Siemens Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Siemens Point-of-care Testing (POCT) for Substance Abuse Product
Table 89. Siemens Recent Developments/Updates
Table 90. Beijing Hotgen Biotech Company Information
Table 91. Beijing Hotgen Biotech Description and Business Overview
Table 92. Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Product
Table 94. Beijing Hotgen Biotech Recent Developments/Updates
Table 95. Hangzhou Biotest Biotech CO.,LTD Company Information
Table 96. Hangzhou Biotest Biotech CO.,LTD Description and Business Overview
Table 97. Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Product
Table 99. Hangzhou Biotest Biotech CO.,LTD Recent Developments/Updates
Table 100. Assure Tech Company Information
Table 101. Assure Tech Description and Business Overview
Table 102. Assure Tech Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Assure Tech Point-of-care Testing (POCT) for Substance Abuse Product
Table 104. Assure Tech Recent Developments/Updates
Table 105. Orient Gene Company Information
Table 106. Orient Gene Description and Business Overview
Table 107. Orient Gene Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Orient Gene Point-of-care Testing (POCT) for Substance Abuse Product
Table 109. Orient Gene Recent Developments/Updates
Table 110. Thermo Fisher Company Information
Table 111. Thermo Fisher Description and Business Overview
Table 112. Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Product
Table 114. Thermo Fisher Recent Developments/Updates
Table 115. Guangzhou Wondfo Biotech Co.,Ltd. Company Information
Table 116. Guangzhou Wondfo Biotech Co.,Ltd. Description and Business Overview
Table 117. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product
Table 119. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
Table 120. Hangzhou Alltest Biotech Co.,Ltd. Company Information
Table 121. Hangzhou Alltest Biotech Co.,Ltd. Description and Business Overview
Table 122. Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product
Table 124. Hangzhou Alltest Biotech Co.,Ltd. Recent Developments/Updates
Table 125. Beckman Coulter Company Information
Table 126. Beckman Coulter Description and Business Overview
Table 127. Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Product
Table 129. Beckman Coulter Recent Developments/Updates
Table 130. Bio-Rad Company Information
Table 131. Bio-Rad Description and Business Overview
Table 132. Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Product
Table 134. Bio-Rad Recent Developments/Updates
Table 135. BioMerieux Company Information
Table 136. BioMerieux Description and Business Overview
Table 137. BioMerieux Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. BioMerieux Point-of-care Testing (POCT) for Substance Abuse Product
Table 139. BioMerieux Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Point-of-care Testing (POCT) for Substance Abuse Distributors List
Table 143. Point-of-care Testing (POCT) for Substance Abuse Customers List
Table 144. Point-of-care Testing (POCT) for Substance Abuse Market Trends
Table 145. Point-of-care Testing (POCT) for Substance Abuse Market Drivers
Table 146. Point-of-care Testing (POCT) for Substance Abuse Market Challenges
Table 147. Point-of-care Testing (POCT) for Substance Abuse Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Point-of-care Testing (POCT) for Substance Abuse
Figure 2. Global Point-of-care Testing (POCT) for Substance Abuse Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Point-of-care Testing (POCT) for Substance Abuse Market Share by Type: 2024 & 2031
Figure 4. Based on Colloidal Gold Product Picture
Figure 5. Based on Fluorescence Immunochromatography Product Picture
Figure 6. Global Point-of-care Testing (POCT) for Substance Abuse Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Point-of-care Testing (POCT) for Substance Abuse Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Diagnostic Center
Figure 10. Road Traffic Safety
Figure 11. Military
Figure 12. Others
Figure 13. Global Point-of-care Testing (POCT) for Substance Abuse Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Point-of-care Testing (POCT) for Substance Abuse Market Size (2020-2031) & (US$ Million)
Figure 15. Global Point-of-care Testing (POCT) for Substance Abuse Sales (2020-2031) & (K Units)
Figure 16. Global Point-of-care Testing (POCT) for Substance Abuse Average Price (US$/Unit) & (2020-2031)
Figure 17. Point-of-care Testing (POCT) for Substance Abuse Report Years Considered
Figure 18. Point-of-care Testing (POCT) for Substance Abuse Sales Share by Manufacturers in 2024
Figure 19. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Point-of-care Testing (POCT) for Substance Abuse Players: Market Share by Revenue in Point-of-care Testing (POCT) for Substance Abuse in 2024
Figure 21. Point-of-care Testing (POCT) for Substance Abuse Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Point-of-care Testing (POCT) for Substance Abuse Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Country (2020-2031)
Figure 24. North America Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Country (2020-2031)
Figure 25. United States Point-of-care Testing (POCT) for Substance Abuse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Point-of-care Testing (POCT) for Substance Abuse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Country (2020-2031)
Figure 28. Europe Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Country (2020-2031)
Figure 29. Germany Point-of-care Testing (POCT) for Substance Abuse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Point-of-care Testing (POCT) for Substance Abuse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Point-of-care Testing (POCT) for Substance Abuse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Point-of-care Testing (POCT) for Substance Abuse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Point-of-care Testing (POCT) for Substance Abuse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Region (2020-2031)
Figure 36. China Point-of-care Testing (POCT) for Substance Abuse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Point-of-care Testing (POCT) for Substance Abuse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Point-of-care Testing (POCT) for Substance Abuse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Point-of-care Testing (POCT) for Substance Abuse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Point-of-care Testing (POCT) for Substance Abuse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Point-of-care Testing (POCT) for Substance Abuse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Point-of-care Testing (POCT) for Substance Abuse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Country (2020-2031)
Figure 44. Latin America Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Point-of-care Testing (POCT) for Substance Abuse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Point-of-care Testing (POCT) for Substance Abuse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Point-of-care Testing (POCT) for Substance Abuse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Point-of-care Testing (POCT) for Substance Abuse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Point-of-care Testing (POCT) for Substance Abuse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Point-of-care Testing (POCT) for Substance Abuse Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Point-of-care Testing (POCT) for Substance Abuse by Type (2020-2031)
Figure 54. Global Revenue Market Share of Point-of-care Testing (POCT) for Substance Abuse by Type (2020-2031)
Figure 55. Global Point-of-care Testing (POCT) for Substance Abuse Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Point-of-care Testing (POCT) for Substance Abuse by Application (2020-2031)
Figure 57. Global Revenue Market Share of Point-of-care Testing (POCT) for Substance Abuse by Application (2020-2031)
Figure 58. Global Point-of-care Testing (POCT) for Substance Abuse Price (US$/Unit) by Application (2020-2031)
Figure 59. Point-of-care Testing (POCT) for Substance Abuse Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
